Market Cap 2.87B
Revenue (ttm) 423.24M
Net Income (ttm) -43.19M
EPS (ttm) N/A
PE Ratio 972.50
Forward PE 37.52
Profit Margin -10.20%
Debt to Equity Ratio 0.00
Volume 789,400
Avg Vol 429,896
Day's Range N/A - N/A
Shares Out 74.11M
Stochastic %K 71%
Beta 0.16
Analysts Strong Sell
Price Target $48.50

Company Profile

Kiniksa Pharmaceuticals International, plc, a biopharmaceutical company, developing and commercializing novel therapies for diseases with unmet need and focuses on cardiovascular indications worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatment of recurrent pericarditis, which is an inflammatory cardiovascular disease; Vixarelimab, a monoclonal antibody, that is in Phase 2b clinical trial for the treatment of prurigo nodularis, a chron...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 781 431 9100
Address:
23 Old Bond Street, Floor 3, London, United Kingdom
ObeCalp
ObeCalp Oct. 25 at 12:15 AM
$RLAY Adding $KNSA to the "fishy" bucket.
0 · Reply
Night_Owl_Biotech
Night_Owl_Biotech Oct. 21 at 7:40 PM
$FOLD continues to trade at lower multiples of projected sales versus 3 peers with like dollar forecasts & gross margin profiles. FOLD is currently defending its patent rights against a generic pharma hoping to sell a biosimilar. We suspect this could be the reason why FOLD does not trade at like multiples versus its peers $MIRM $TARS $KNSA Again by peers we mean those commercial-stage bios with similar revenue projections & patent lives. This is not investment advice. $IBB
2 · Reply
JarvisFlow
JarvisFlow Oct. 17 at 3:23 PM
Citigroup has adjusted their stance on Kiniksa Pharmaceuticals ( $KNSA ), setting the rating to Buy with a target price of 45 → 50.
0 · Reply
ap20
ap20 Oct. 15 at 7:45 PM
$KNSA anybody sniffing a 40?
1 · Reply
limitsean
limitsean Oct. 5 at 9:19 AM
$KNSA Biotech with clinical catalyst. High short interest. Volatility expansion expected. Pure binary event risk.
0 · Reply
BDE_Worldwide
BDE_Worldwide Sep. 29 at 9:47 PM
$KNSA very quiet board for hitting all time highs.. 🤔 Takeout candidate in 2026.
1 · Reply
Rascal7777777
Rascal7777777 Sep. 29 at 7:23 PM
1 · Reply
ap20
ap20 Sep. 29 at 6:20 PM
$KNSA Cowen upgrade to 60. 52 week and I think all time high today on decent volume.
0 · Reply
xbibackto65s
xbibackto65s Sep. 25 at 8:26 PM
$KNSA fn dick tease all day w flat and slight green!
0 · Reply
xbibackto65s
xbibackto65s Sep. 19 at 3:19 PM
$KNSA addind more
0 · Reply
Latest News on KNSA
Kiniksa Pharmaceuticals: Making Steady Progress

May 5, 2025, 4:51 PM EDT - 6 months ago

Kiniksa Pharmaceuticals: Making Steady Progress


Big Pipeline Updates From Kiniksa Pharmaceuticals

Feb 25, 2025, 4:14 PM EST - 8 months ago

Big Pipeline Updates From Kiniksa Pharmaceuticals


Kiniksa Pharmaceuticals Provides Corporate Update

Jan 4, 2024, 7:30 AM EST - 1 year ago

Kiniksa Pharmaceuticals Provides Corporate Update


ObeCalp
ObeCalp Oct. 25 at 12:15 AM
$RLAY Adding $KNSA to the "fishy" bucket.
0 · Reply
Night_Owl_Biotech
Night_Owl_Biotech Oct. 21 at 7:40 PM
$FOLD continues to trade at lower multiples of projected sales versus 3 peers with like dollar forecasts & gross margin profiles. FOLD is currently defending its patent rights against a generic pharma hoping to sell a biosimilar. We suspect this could be the reason why FOLD does not trade at like multiples versus its peers $MIRM $TARS $KNSA Again by peers we mean those commercial-stage bios with similar revenue projections & patent lives. This is not investment advice. $IBB
2 · Reply
JarvisFlow
JarvisFlow Oct. 17 at 3:23 PM
Citigroup has adjusted their stance on Kiniksa Pharmaceuticals ( $KNSA ), setting the rating to Buy with a target price of 45 → 50.
0 · Reply
ap20
ap20 Oct. 15 at 7:45 PM
$KNSA anybody sniffing a 40?
1 · Reply
limitsean
limitsean Oct. 5 at 9:19 AM
$KNSA Biotech with clinical catalyst. High short interest. Volatility expansion expected. Pure binary event risk.
0 · Reply
BDE_Worldwide
BDE_Worldwide Sep. 29 at 9:47 PM
$KNSA very quiet board for hitting all time highs.. 🤔 Takeout candidate in 2026.
1 · Reply
Rascal7777777
Rascal7777777 Sep. 29 at 7:23 PM
1 · Reply
ap20
ap20 Sep. 29 at 6:20 PM
$KNSA Cowen upgrade to 60. 52 week and I think all time high today on decent volume.
0 · Reply
xbibackto65s
xbibackto65s Sep. 25 at 8:26 PM
$KNSA fn dick tease all day w flat and slight green!
0 · Reply
xbibackto65s
xbibackto65s Sep. 19 at 3:19 PM
$KNSA addind more
0 · Reply
xbibackto65s
xbibackto65s Sep. 18 at 7:09 PM
$KNSA wake up!!! look at xbi!!
0 · Reply
xbibackto65s
xbibackto65s Sep. 15 at 3:21 PM
$KNSA Adding
0 · Reply
ap20
ap20 Sep. 8 at 4:54 PM
$KNSA Nice little run continues.
0 · Reply
Massimino
Massimino Sep. 8 at 12:49 PM
$KNSA my best performing stock this year!!
0 · Reply
Doozio
Doozio Sep. 5 at 12:52 PM
$KNSA out of the tightness during 🐒🍌🧠⏰♾️
0 · Reply
Happy_Feet19
Happy_Feet19 Sep. 3 at 10:02 PM
$KNSA Good fireside chat today. They have a very detailed updated corp. presentation on their website. I have ask this question in the past years that I have owned this stock but can anyone tell me why this great company with awesome revenue with no competition is not for sale. I would think some big parma like Roche would buy them out. Thoughts?
1 · Reply
ap20
ap20 Sep. 3 at 7:12 PM
$KNSA nice move today.
0 · Reply
ap20
ap20 Aug. 31 at 1:41 AM
$KNSA 26 days without a post.. I thought I’d post something.. It hasn’t gone down!
0 · Reply
topstockalerts
topstockalerts Aug. 4 at 10:56 AM
Pre Market Top Gainers PT2 $UNIT $SLE $BTAI $KNSA $BLDE
0 · Reply
WallStreetBuyDip
WallStreetBuyDip Aug. 3 at 2:59 AM
$KNSA Trading at $31.98, hitting the highest point today. With an average volume of 551,318, today's volume is lower than yesterday's.
0 · Reply
BDE_Worldwide
BDE_Worldwide Aug. 1 at 8:35 PM
$KNSA really digging this move today! Finally time to put $30 in the rearview??
0 · Reply
OptionRunners
OptionRunners Aug. 1 at 7:16 PM
$KNSA taking out the earnings highs from a few days ago. Really strong today in this ugly tape. Calls up to about $3.70 now Guy in the comments was arguing with me about how they were selling them lol. Careful who you follow.
0 · Reply